BHC
Bausch Health Companies Inc.
Company overview
- Market capitalization
- $2.16B
- Employees
- 20,300
- Latest publication
- 2026-09-29
About Bausch Health Companies Inc.
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q2 20232023-06-30 · USD | Q3 20222022-09-30 · USD | Q4 20202020-12-31 · USD | Q3 20202020-09-30 · USD | Q1 20202020-03-31 · USD | Q3 20192019-09-30 · USD | Q2 20192019-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,489,038,232USD | 2,167,000,000USD | 2,046,000,000USD | 2,213,000,000USD | 2,138,000,000USD | 2,012,000,000USD | 2,209,000,000USD | 2,152,000,000USD |
| Cost Of Revenue | 965,439,156USD | 649,000,000USD | 584,000,000USD | 645,000,000USD | 590,000,000USD | 519,000,000USD | 584,000,000USD | 594,000,000USD |
| Gross Profit | 1,523,599,076USD | 1,518,000,000USD | 1,462,000,000USD | 1,568,000,000USD | 1,548,000,000USD | 1,493,000,000USD | 1,625,000,000USD | 1,558,000,000USD |
| Research Development | 160,742,167USD | 156,000,000USD | 133,000,000USD | 132,000,000USD | 115,000,000USD | 123,000,000USD | 124,000,000USD | 124,000,000USD |
| Selling General Administrative | 861,000,000USD | 711,000,000USD | 661,000,000USD | 168,000,000USD | 572,000,000USD | 633,000,000USD | 648,000,000USD | 651,000,000USD |
| Unclassified Operating Expenses | -11,926,339USD | 239,000,000USD | 424,000,000USD | 822,000,000USD | 401,000,000USD | 489,000,000USD | 524,000,000USD | 526,000,000USD |
| Total Operating Expenses | 1,009,815,828USD | 1,106,000,000USD | 1,218,000,000USD | 1,573,000,000USD | 1,088,000,000USD | 1,245,000,000USD | 1,296,000,000USD | 1,301,000,000USD |
| Operating Income | 513,783,248USD | 412,000,000USD | 244,000,000USD | -5,000,000USD | 460,000,000USD | 248,000,000USD | 329,000,000USD | 257,000,000USD |
| Interest Income | 10,000,000USD | 7,000,000USD | 375,000,000USD | 381,000,000USD | 385,000,000USD | 7,000,000USD | 2,000,000USD | 3,000,000USD |
| Interest Expense | 396,431,604USD | 319,000,000USD | 385,000,000USD | 379,000,000USD | 374,000,000USD | 396,000,000USD | 406,000,000USD | 409,000,000USD |
| Net Interest Income | -392,000,000USD | -312,000,000USD | -382,000,000USD | -377,000,000USD | -372,000,000USD | -389,000,000USD | -404,000,000USD | -406,000,000USD |
| Income Before Tax | -1,335,244,757USD | 79,000,000USD | 439,000,000USD | -394,000,000USD | 75,000,000USD | -178,000,000USD | -66,000,000USD | -179,000,000USD |
| Income Tax Expense | 75,933,416USD | 52,000,000USD | 36,000,000USD | -242,000,000USD | 5,000,000USD | -26,000,000USD | -18,000,000USD | -9,000,000USD |
| Tax Provision | 77,000,000USD | 52,000,000USD | 36,000,000USD | -242,000,000USD | 5,000,000USD | -26,000,000USD | -18,000,000USD | -9,000,000USD |
| Net Income | -1,403,288,987USD | 26,000,000USD | 399,000,000USD | -153,000,000USD | 71,000,000USD | -152,000,000USD | -49,000,000USD | -171,000,000USD |
| Net Income From Continuing Ops | -1,431,000,000USD | 27,000,000USD | 403,000,000USD | -152,000,000USD | 70,000,000USD | -152,000,000USD | -48,000,000USD | -170,000,000USD |
| Ebit | -938,813,153USD | 381,000,000USD | 378,000,000USD | 447,000,000USD | 482,000,000USD | 301,000,000USD | 378,000,000USD | 296,000,000USD |
| Ebitda | -647,899,414USD | 696,000,000USD | 713,000,000USD | 875,000,000USD | 918,000,000USD | 782,000,000USD | 898,000,000USD | 827,000,000USD |
| Depreciation And Amortization | 290,913,739USD | 315,000,000USD | 335,000,000USD | 428,000,000USD | 436,000,000USD | 481,000,000USD | 520,000,000USD | 531,000,000USD |
| Reconciled Depreciation | 295,000,000USD | 269,000,000USD | 335,000,000USD | 428,000,000USD | 436,000,000USD | 481,000,000USD | 520,000,000USD | 531,000,000USD |
| Total Other Income Expense Net | -1,849,028,005USD | -333,000,000USD | 195,000,000USD | -389,000,000USD | -385,000,000USD | -426,000,000USD | -395,000,000USD | -436,000,000USD |
| Minority Interest | 8,000,000USD | 1,000,000USD | 4,000,000USD | 1,000,000USD | -1,000,000USD | 71,000,000USD | 1,000,000USD | 1,000,000USD |
| Non Operating Income Net Other | — | -14,000,000USD | 580,000,000USD | -10,000,000USD | -11,000,000USD | -30,000,000USD | 11,000,000USD | -27,000,000USD |
| Net Income Applicable To Common Shares | — | 26,000,000USD | 399,000,000USD | -153,000,000USD | 71,000,000USD | -152,000,000USD | -49,000,000USD | -171,000,000USD |
| Selling And Marketing Expenses | — | — | — | 451,000,000USD | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20202020-12-31 · USD | FY 20172017-12-31 · USD | FY 20142014-12-31 · USD | FY 20122012-12-31 · USD | FY 20112011-12-31 · USD | FY 20102010-12-31 · USD | FY 20092009-12-31 · USD | FY 20072007-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 8,027,000,000USD | 8,724,000,000USD | 8,200,000,000USD | 3,480,400,000USD | 2,463,450,000USD | 1,146,128,000USD | 820,430,000USD | 842,818,000USD |
| Cost Of Revenue | 2,249,000,000USD | 2,548,000,000USD | 2,203,000,000USD | 890,900,000USD | 726,832,000USD | 405,750,000USD | 325,093,000USD | 223,680,000USD |
| Gross Profit | 5,778,000,000USD | 6,176,000,000USD | 5,997,000,000USD | 2,589,500,000USD | 1,736,618,000USD | 740,378,000USD | 495,337,000USD | 619,138,000USD |
| Research Development | 485,000,000USD | 369,000,000USD | 266,000,000USD | 79,100,000USD | 174,887,000USD | 157,556,000USD | 14,148,000USD | 118,117,000USD |
| Selling General Administrative | 1,916,000,000USD | 2,120,000,000USD | 1,591,000,000USD | 812,862,000USD | 584,313,000USD | 367,418,000USD | 190,388,000USD | 161,001,000USD |
| Selling And Marketing Expenses | 451,000,000USD | 462,000,000USD | 435,000,000USD | 157,600,000USD | — | — | — | — |
| Unclassified Operating Expenses | 2,250,000,000USD | 3,123,000,000USD | 1,704,000,000USD | 1,458,538,000USD | 546,828,000USD | -180,117,000USD | -11,787,000USD | 151,338,000USD |
| Total Operating Expenses | 5,102,000,000USD | 6,074,000,000USD | 3,996,000,000USD | 2,508,100,000USD | 1,306,028,000USD | 344,857,000USD | 192,749,000USD | 430,456,000USD |
| Operating Income | 676,000,000USD | 102,000,000USD | 2,001,000,000USD | 79,685,000USD | 525,319,434USD | -110,085,000USD | 181,154,000USD | 188,014,000USD |
| Interest Income | 1,551,000,000USD | 12,000,000USD | — | — | — | — | — | — |
| Interest Expense | 1,534,000,000USD | 1,840,000,000USD | 971,000,000USD | 481,600,000USD | 330,442,000USD | 84,307,000USD | 25,418,000USD | 0USD |
| Net Interest Income | -1,521,000,000USD | -1,828,000,000USD | — | — | — | — | — | — |
| Income Before Tax | -934,000,000USD | -1,741,000,000USD | 1,054,000,000USD | -394,228,000USD | -18,000,000USD | -236,263,000USD | 174,955,000USD | 208,739,000USD |
| Income Tax Expense | -375,000,000USD | -4,145,000,000USD | 174,000,000USD | -278,203,000USD | -177,559,000USD | -28,070,000USD | -1,500,000USD | 13,200,000USD |
| Tax Provision | -375,000,000USD | -4,145,000,000USD | — | — | — | — | — | — |
| Net Income | -559,000,000USD | 2,404,000,000USD | 881,000,000USD | -116,025,000USD | 159,559,000USD | -208,193,000USD | 176,455,000USD | 195,539,000USD |
| Net Income From Continuing Ops | -559,000,000USD | 2,404,000,000USD | 912,200,000USD | -116,025,000USD | 159,559,000USD | -208,193,000USD | — | — |
| Ebit | 1,313,000,000USD | 555,000,000USD | 2,298,000,000USD | 803,100,000USD | 306,110,594USD | -151,956,000USD | 199,836,000USD | 188,682,000USD |
| Ebitda | 3,138,000,000USD | 3,413,000,000USD | 3,912,000,000USD | 1,789,300,000USD | 901,348,248USD | 102,548,000USD | 349,096,000USD | 289,450,000USD |
| Depreciation And Amortization | 1,825,000,000USD | 2,858,000,000USD | 1,614,000,000USD | 986,200,000USD | 595,237,654USD | 254,504,000USD | 149,260,000USD | 100,768,000USD |
| Reconciled Depreciation | 1,825,000,000USD | 2,858,000,000USD | — | — | — | — | — | — |
| Total Other Income Expense Net | -1,610,000,000USD | -1,843,000,000USD | -947,000,000USD | -473,913,000USD | -317,959,000USD | -126,178,000USD | -6,199,000USD | 20,725,000USD |
| Non Operating Income Net Other | -76,000,000USD | -3,000,000USD | 23,900,000USD | -517,000USD | 15,082,000USD | -41,871,000USD | — | — |
| Minority Interest | 1,000,000USD | 95,000,000USD | -1,300,000USD | — | — | — | — | — |
| Net Income Applicable To Common Shares | -560,000,000USD | 2,404,000,000USD | 913,500,000USD | -116,025,000USD | 159,559,000USD | -208,193,000USD | 176,455,000USD | 195,539,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 24,498,000,000USD | 26,318,017,834USD | 26,797,851,964USD | 27,266,000,000USD | 26,421,000,000USD | 26,523,000,000USD | 26,540,000,000USD | 26,495,000,000USD |
| Intangible Assets | 4,404,000,000USD | 4,634,550,436USD | 4,825,291,716USD | 5,047,000,000USD | 5,297,000,000USD | 5,551,000,000USD | 5,652,000,000USD | 5,903,000,000USD |
| Other Current Assets | 887,000,000USD | 850,449,489USD | 893,128,528USD | 922,000,000USD | 913,000,000USD | 858,000,000USD | 883,000,000USD | 902,000,000USD |
| Total Liab | 25,580,000,000USD | 25,941,703,918USD | 26,442,198,993USD | 27,119,000,000USD | 26,661,000,000USD | 26,845,000,000USD | 26,782,000,000USD | 26,722,000,000USD |
| Total Stockholder Equity | -2,059,000,000USD | -552,991,803USD | -564,449,238USD | -764,000,000USD | -1,183,000,000USD | -1,279,000,000USD | -1,174,000,000USD | -1,175,000,000USD |
| Other Current Liab | 3,037,000,000USD | 3,277,025,433USD | 3,594,492,668USD | 3,469,000,000USD | 3,354,000,000USD | 3,359,000,000USD | 3,284,000,000USD | 3,260,011,440USD |
| Common Stock | 10,542,000,000USD | 10,496,862,457USD | 10,504,749,978USD | 10,510,000,000USD | 10,508,000,000USD | 10,490,000,000USD | 10,489,000,000USD | 10,483,000,000USD |
| Capital Stock | 10,542,000,000USD | 10,516,000,000USD | 10,515,000,000USD | 10,510,000,000USD | 10,508,000,000USD | 10,490,000,000USD | 10,489,000,000USD | 10,483,000,000USD |
| Retained Earnings | -11,090,000,000USD | -9,649,407,510USD | -9,545,685,786USD | -9,734,000,000USD | -9,882,000,000USD | -9,824,000,000USD | -9,917,000,000USD | -9,832,000,000USD |
| Good Will | 9,807,000,000USD | 11,250,488,470USD | 11,275,997,432USD | 11,298,000,000USD | 11,153,000,000USD | 11,087,000,000USD | 11,171,000,000USD | 11,127,000,000USD |
| Cash | 1,299,000,000USD | 1,322,588,698USD | 1,338,693,768USD | 1,727,000,000USD | 1,134,000,000USD | 1,181,000,000USD | 719,000,000USD | 595,000,000USD |
| Cash And Short Term Investments | 1,299,000,000USD | 1,322,588,698USD | 1,338,693,768USD | 1,727,000,000USD | 1,134,000,000USD | 1,181,000,000USD | 719,000,000USD | 595,000,000USD |
| Total Current Assets | 5,978,000,000USD | 6,145,795,183USD | 6,242,908,474USD | 6,514,000,000USD | 5,732,000,000USD | 5,774,000,000USD | 5,351,000,000USD | 5,211,000,000USD |
| Total Current Liabilities | 4,530,000,000USD | 4,172,393,027USD | 4,788,327,783USD | 4,975,000,000USD | 4,256,000,000USD | 6,752,000,000USD | 4,506,000,000USD | 4,369,000,000USD |
| Net Debt | 19,496,000,000USD | 19,884,746,767USD | 19,682,794,490USD | 20,011,000,000USD | 20,376,000,000USD | 20,435,000,000USD | 20,788,000,000USD | 21,065,000,000USD |
| Short Term Debt | 900,000,000USD | 296,459,504USD | 578,435,590USD | 879,000,000USD | 282,000,000USD | 2,674,000,000USD | 453,000,000USD | 452,000,000USD |
| Short Long Term Debt | 889,000,000USD | 225,000,000USD | 579,000,000USD | 879,000,000USD | 282,000,000USD | 2,674,000,000USD | 453,000,000USD | 452,000,000USD |
| Short Long Term Debt Total | 20,795,000,000USD | 21,207,335,465USD | 21,021,488,258USD | 21,738,000,000USD | 21,510,000,000USD | 21,616,000,000USD | 21,507,000,000USD | 21,660,000,000USD |
| Long Term Debt | 19,875,000,000USD | 20,592,000,000USD | 20,463,000,000USD | 20,859,000,000USD | 21,228,000,000USD | 18,942,000,000USD | 21,054,000,000USD | 21,208,000,000USD |
| Net Receivables | 2,191,000,000USD | 2,346,721,532USD | 2,414,643,908USD | 2,210,000,000USD | 2,072,000,000USD | 2,140,000,000USD | 2,094,000,000USD | 2,102,000,000USD |
| Inventory | 1,601,000,000USD | 1,626,035,464USD | 1,596,442,269USD | 1,655,000,000USD | 1,613,000,000USD | 1,595,000,000USD | 1,655,000,000USD | 1,612,000,000USD |
| Accounts Payable | 593,000,000USD | 598,908,090USD | 615,399,523USD | 627,000,000USD | 620,000,000USD | 656,000,000USD | 667,000,000USD | 579,000,000USD |
| Property Plant Equipment Net | 2,095,000,000USD | 2,070,225,631USD | 2,024,025,055USD | 1,994,000,000USD | 1,882,000,000USD | 1,780,000,000USD | 1,789,000,000USD | 1,738,000,000USD |
| Accumulated Other Comprehensive Income | -1,806,000,000USD | -1,756,797,064USD | -1,798,245,360USD | -1,790,000,000USD | -2,029,000,000USD | -2,179,000,000USD | -1,947,000,000USD | -2,007,000,000USD |
| Common Stock Shares Outstanding | 372,800,000shares | 370,531,987shares | 375,500,000shares | 373,100,000shares | 369,600,000shares | 372,000,000shares | 368,400,000shares | 370,200,000shares |
| Non Current Assets Total | 18,520,000,000USD | 20,172,222,651USD | 20,554,943,490USD | 20,752,000,000USD | 20,689,000,000USD | 20,749,000,000USD | 21,189,000,000USD | 21,284,000,000USD |
| Non Current Liabilities Total | 21,050,000,000USD | 21,769,310,891USD | 21,653,871,210USD | 22,144,000,000USD | 22,405,000,000USD | 20,093,000,000USD | 22,276,000,000USD | 22,353,000,000USD |
| Non Current Liabilities Other | 976,000,000USD | 1,047,000,000USD | 1,067,000,000USD | 1,141,000,000USD | 1,043,000,000USD | 1,023,000,000USD | 1,053,000,000USD | 975,000,000USD |
| Non Currrent Assets Other | 369,000,000USD | 377,312,097USD | 381,627,626USD | 388,000,000USD | 380,000,000USD | 363,000,000USD | 389,000,000USD | 329,000,000USD |
| Net Working Capital | 1,448,000,000USD | 1,977,000,000USD | 1,456,000,000USD | 1,539,000,000USD | 1,476,000,000USD | -978,000,000USD | 845,000,000USD | 842,000,000USD |
| Unclassified Non Current Assets | 1,845,000,000USD | -381,353,983USD | -383,998,339USD | -388,000,000USD | -380,000,000USD | -363,000,000USD | -389,000,000USD | 2,186,999,999USD |
| Unclassified Current Liabilities | -889,000,000USD | -225,000,000USD | -578,999,998USD | -879,000,000USD | -282,000,000USD | -2,611,000,000USD | -351,000,000USD | -452,000,003USD |
| Unclassified Equity | -10,247,000,000USD | -10,159,649,686USD | -10,240,268,070USD | -10,260,000,000USD | -10,288,000,000USD | -10,256,000,000USD | -10,288,000,000USD | -10,302,000,000USD |
| Other Assets | — | 2,221,000,000USD | 2,432,000,000USD | 2,413,000,000USD | 2,357,000,000USD | 2,331,000,000USD | 2,577,000,000USD | 1USD |
| Cash And Equivalents | — | 1,309,000,000USD | 1,308,000,000USD | 1,727,000,000USD | 1,134,000,000USD | 1,181,000,000USD | 719,000,000USD | — |
| Property Plant Equipment Gross | — | 4,498,000,000USD | — | — | — | 3,924,000,000USD | — | — |
| Current Deferred Revenue | — | — | — | — | — | — | — | 77,988,563USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 26,318,017,834USD | 26,523,000,000USD | 27,350,000,000USD | 25,686,000,000USD | 29,202,000,000USD | 31,199,000,000USD | 33,863,000,000USD | 27,447,000,000USD |
| Intangible Assets | 4,634,550,436USD | 5,551,000,000USD | 6,456,000,000USD | 5,800,000,000USD | 6,948,000,000USD | 8,445,000,000USD | 10,201,000,000USD | 12,001,000,000USD |
| Other Current Assets | 850,449,489USD | 858,000,000USD | 1,107,000,000USD | 803,000,000USD | 720,000,000USD | 855,000,000USD | 780,000,000USD | 691,000,000USD |
| Total Liab | 25,941,703,918USD | 26,845,000,000USD | 27,432,000,000USD | 25,426,000,000USD | 29,236,000,000USD | 30,594,000,000USD | 32,727,000,000USD | 29,677,000,000USD |
| Total Stockholder Equity | -552,991,803USD | -1,279,000,000USD | -1,022,000,000USD | -692,000,000USD | -34,000,000USD | 605,000,000USD | 1,063,000,000USD | 2,733,000,000USD |
| Other Current Liab | 3,277,025,433USD | 3,301,000,000USD | 3,086,000,000USD | 2,958,000,000USD | 4,791,000,000USD | 4,576,000,000USD | 4,315,000,000USD | 3,030,000,000USD |
| Common Stock | 10,496,862,457USD | 10,490,000,000USD | 10,423,000,000USD | 10,391,000,000USD | 10,317,000,000USD | 10,227,000,000USD | 10,172,000,000USD | 10,121,000,000USD |
| Capital Stock | 10,516,000,000USD | 10,490,000,000USD | 10,423,000,000USD | 10,391,000,000USD | 10,317,000,000USD | 10,227,000,000USD | 10,172,000,000USD | 10,121,000,000USD |
| Retained Earnings | -9,649,407,510USD | -9,824,000,000USD | -9,778,000,000USD | -9,186,000,000USD | -8,961,000,000USD | -8,013,000,000USD | -7,452,000,000USD | -5,664,000,000USD |
| Good Will | 11,250,488,470USD | 11,087,000,000USD | 11,183,000,000USD | 11,547,000,000USD | 12,457,000,000USD | 13,044,000,000USD | 13,126,000,000USD | 13,142,000,000USD |
| Other Assets | 2,006,000,000USD | 2,120,000,000USD | 2,223,000,000USD | 2,271,000,000USD | 2,345,000,000USD | 2,801,000,000USD | 1,830,000,000USD | -1,557,000,000USD |
| Cash | 1,322,588,698USD | 1,181,000,000USD | 947,000,000USD | 564,000,000USD | 582,000,000USD | 605,000,000USD | 3,243,000,000USD | 721,000,000USD |
| Cash And Equivalents | 1,309,000,000USD | 1,181,000,000USD | 947,000,000USD | 564,000,000USD | 582,000,000USD | 605,000,000USD | 3,243,000,000USD | 721,000,000USD |
| Cash And Short Term Investments | 1,322,588,698USD | 1,181,000,000USD | 947,000,000USD | 564,000,000USD | 582,000,000USD | 605,000,000USD | 3,243,000,000USD | 721,000,000USD |
| Total Current Assets | 6,145,795,183USD | 5,774,000,000USD | 5,596,000,000USD | 4,247,000,000USD | 5,607,000,000USD | 5,342,000,000USD | 6,969,000,000USD | 723,000,000USD |
| Total Current Liabilities | 4,172,393,027USD | 6,752,000,000USD | 4,302,000,000USD | 3,941,000,000USD | 5,198,000,000USD | 4,913,000,000USD | 6,248,000,000USD | 3,836,000,000USD |
| Net Debt | 19,884,746,767USD | 20,645,009,726USD | 21,441,000,000USD | 20,202,000,000USD | 22,072,000,000USD | 23,320,000,000USD | 22,652,000,000USD | 23,584,000,000USD |
| Short Term Debt | 296,459,504USD | 2,732,000,000USD | 450,000,000USD | 432,000,000USD | 49,932,319USD | 52,000,000USD | 1,234,000,000USD | 228,000,000USD |
| Short Long Term Debt | 225,000,000USD | 2,674,000,000USD | 450,000,000USD | 432,000,000USD | — | — | 1,234,000,000USD | 228,000,000USD |
| Short Long Term Debt Total | 21,207,335,465USD | 21,826,009,726USD | 22,388,000,000USD | 20,766,000,000USD | 22,703,932,319USD | 23,977,000,000USD | 25,895,000,000USD | 24,305,000,000USD |
| Long Term Debt | 20,592,000,000USD | 18,942,000,000USD | 21,938,000,000USD | 20,334,000,000USD | 22,654,000,000USD | 23,925,000,000USD | 24,661,000,000USD | 24,077,000,000USD |
| Net Receivables | 2,346,721,532USD | 2,140,000,000USD | 1,998,000,000USD | 1,790,000,000USD | 1,775,000,000USD | 1,577,000,000USD | 1,839,000,000USD | 1,865,000,000USD |
| Inventory | 1,626,035,464USD | 1,595,000,000USD | 1,544,000,000USD | 1,090,000,000USD | 993,000,000USD | 1,094,000,000USD | 1,107,000,000USD | 934,000,000USD |
| Accounts Payable | 598,908,090USD | 656,000,000USD | 719,000,000USD | 521,000,000USD | 407,000,000USD | 337,000,000USD | 503,000,000USD | 411,000,000USD |
| Property Plant Equipment Net | 2,070,225,631USD | 1,780,000,000USD | 1,707,000,000USD | 1,600,000,000USD | 1,598,000,000USD | 1,567,000,000USD | 1,466,000,000USD | 1,353,000,000USD |
| Property Plant Equipment Gross | 4,498,000,000USD | 3,924,000,000USD | 3,790,000,000USD | 3,520,000,000USD | 3,418,000,000USD | 1,567,000,000USD | 1,466,000,000USD | 1,353,000,000USD |
| Accumulated Other Comprehensive Income | -1,756,797,064USD | -2,179,000,000USD | -1,881,000,000USD | -2,056,000,000USD | -1,924,000,000USD | -2,133,000,000USD | -2,086,000,000USD | -2,137,000,000USD |
| Common Stock Shares Outstanding | 375,000,000shares | 368,000,000shares | 364,900,000shares | 362,000,000shares | 358,900,000shares | 355,000,000shares | 352,100,000shares | 349,871,102shares |
| Non Current Assets Total | 20,172,222,651USD | 20,749,000,000USD | 21,754,000,000USD | 21,439,000,000USD | 23,595,000,000USD | 25,857,000,000USD | 26,894,000,000USD | 28,281,000,000USD |
| Non Current Liabilities Total | 21,769,310,891USD | 20,093,000,000USD | 23,130,000,000USD | 21,485,000,000USD | 24,038,000,000USD | 25,681,000,000USD | 26,479,000,000USD | 25,841,000,000USD |
| Non Current Liabilities Other | 1,047,000,000USD | 1,023,000,000USD | 1,029,000,000USD | 949,000,000USD | 855,000,000USD | 1,228,000,000USD | 1,113,000,000USD | 879,000,000USD |
| Non Currrent Assets Other | 377,312,097USD | 363,000,000USD | 307,000,000USD | 326,000,000USD | 340,000,000USD | 664,000,000USD | 411,000,000USD | 109,000,000USD |
| Net Working Capital | 1,977,000,000USD | -978,000,000USD | 1,294,000,000USD | 306,000,000USD | 409,000,000USD | 429,000,000USD | 721,000,000USD | 375,000,000USD |
| Unclassified Current Liabilities | -225,000,000USD | -2,611,000,000USD | -2,495,000,000USD | -402,000,000USD | — | -52,000,000USD | -3,432,000,000USD | -228,000,000USD |
| Unclassified Equity | -10,159,649,686USD | -10,256,000,000USD | -10,209,000,000USD | -10,232,000,000USD | -9,783,000,000USD | -9,703,000,000USD | -9,743,000,000USD | -9,708,000,000USD |
| Current Deferred Revenue | — | — | 2,092,000,000USD | — | -49,932,319USD | -52,000,000USD | 2,394,000,000USD | 167,000,000USD |
| Deferred Long Term Liab | — | — | — | 202,000,000USD | 529,000,000USD | 528,000,000USD | 705,000,000USD | 885,000,000USD |
| Other Liab | — | — | — | 967,000,000USD | 1,170,000,000USD | 1,529,000,000USD | 1,578,000,000USD | 1,764,000,000USD |
| Net Tangible Assets | — | — | — | -18,039,000,000USD | -19,511,000,000USD | -20,954,000,000USD | -22,264,000,000USD | -22,410,000,000USD |
| Unclassified Non Current Liabilities | — | — | — | -967,000,000USD | -1,170,000,000USD | -1,529,000,000USD | -1,578,000,000USD | -1,764,000,000USD |
| Unclassified Current Assets | — | — | — | — | 1,537,000,000USD | 1,211,000,000USD | — | -3,488,000,000USD |
| Unclassified Non Current Assets | — | — | — | — | — | -664,000,000USD | — | 1,676,000,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -113,721,582USD | 181,000,000USD | 128,000,000USD | -86,000,000USD | 98,000,000USD | -85,683,743USD | 9,997,937USD | -77,000,000USD |
| Depreciation | 294,457,668USD | 306,000,000USD | 307,000,000USD | 305,000,000USD | 307,000,000USD | 324,590,182USD | 317,934,417USD | 320,000,000USD |
| Stock Based Compensation | 84,000,000USD | 43,000,000USD | 46,000,000USD | 43,000,000USD | 43,000,000USD | 38,000,000USD | 36,000,000USD | 33,000,000USD |
| Other Non Cash Items | 352,757,808USD | -48,000,000USD | -241,000,000USD | 23,000,000USD | 99,159,000USD | 41,279,107USD | 63,395,956USD | 27,000,000USD |
| Change To Account Receivables | 66,280,899USD | -218,000,000USD | -91,000,000USD | 110,000,000USD | -104,000,000USD | 23,087,429USD | -71,935,623USD | -63,000,000USD |
| Change To Inventory | -5,082,496USD | 16,000,000USD | 7,000,000USD | -30,000,000USD | -49,000,000USD | -42,182,332USD | -32,818,178USD | -144,000,000USD |
| Change In Working Capital | -195,341,655USD | -53,000,000USD | 91,000,000USD | -65,000,000USD | -116,000,000USD | 126,518,496USD | 31,511,493USD | -35,000,000USD |
| Total Cash From Operating Activities | 495,919,506USD | 405,000,000USD | 289,000,000USD | 211,000,000USD | 601,000,000USD | 403,686,271USD | 378,744,097USD | 211,000,000USD |
| Capital Expenditures | -93,391,278USD | -91,000,000USD | -99,000,000USD | -124,000,000USD | -107,000,000USD | -71,300,847USD | -78,030,635USD | -83,000,000USD |
| Free Cash Flow | 402,528,228USD | 314,000,000USD | 190,000,000USD | 87,000,000USD | 494,000,000USD | 332,385,424USD | 300,713,461USD | 128,000,000USD |
| Investments | -3,000,000USD | -83,000,000USD | -100,000,000USD | -130,000,000USD | -200,000,000USD | -102,000,000USD | -79,000,000USD | -73,000,000USD |
| Total Cashflows From Investing Activities | -286,711,578USD | -83,000,000USD | -100,000,000USD | -130,000,000USD | -200,000,000USD | -102,428,024USD | -78,957,652USD | -73,000,000USD |
| Net Borrowings | -219,000,000USD | -705,000,000USD | 405,000,000USD | -118,000,000USD | 95,000,000USD | -164,000,000USD | — | — |
| Total Cash From Financing Activities | -231,654,147USD | -719,000,000USD | 358,000,000USD | -146,000,000USD | 85,000,000USD | -186,806,431USD | -423,365,399USD | -340,000,000USD |
| Change In Cash | -16,105,070USD | -403,000,000USD | 586,000,000USD | -44,000,000USD | 451,000,000USD | 125,906,065USD | -131,313,075USD | -207,000,000USD |
| Begin Period Cash Flow | 1,338,693,768USD | 1,743,000,000USD | 1,157,000,000USD | 1,201,000,000USD | 750,000,000USD | 622,908,633USD | 754,221,708USD | 962,000,000USD |
| End Period Cash Flow | 1,322,588,698USD | 1,340,000,000USD | 1,743,000,000USD | 1,157,000,000USD | 1,201,000,000USD | 748,814,698USD | 622,908,633USD | 755,000,000USD |
| Other Cashflows From Investing Activities | -8,627USD | 13,000,000USD | -1,000,000USD | -3,000,000USD | -5,013,000USD | 7,029,136USD | 43,799USD | 6,000,000USD |
| Other Cashflows From Financing Activities | -9,120,891USD | -14,000,000USD | -44,000,000USD | -28,000,000USD | 1,583,000USD | -22,092,169USD | -9,087,764USD | -25,000,000USD |
| Unclassified Operating Cash Flow | 73,767,267USD | -24,000,000USD | -42,000,000USD | -9,000,000USD | 169,841,000USD | -41,017,771USD | -80,095,706USD | -57,000,000USD |
| Unclassified Investing Cash Flow | -190,311,673USD | 78,000,000USD | 100,000,000USD | 127,000,000USD | 112,013,000USD | 63,843,687USD | 78,029,184USD | 77,000,000USD |
| Unclassified Financing Cash Flow | -3,533,256USD | — | — | — | -11,583,000USD | -18,714,262USD | -410,277,635USD | -301,000,000USD |
| Dividends Paid | — | 0USD | 0USD | 0USD | — | 0USD | 0USD | 0USD |
| Sale Purchase Of Stock | — | 3,000,000USD | -3,000,000USD | — | 0USD | 18,000,000USD | -4,000,000USD | -14,000,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 120,000,000USD | -72,000,000USD | -611,000,000USD | -212,000,000USD | -937,000,000USD | -559,000,000USD | -1,783,000,000USD | -4,144,000,000USD |
| Depreciation | 1,208,000,000USD | 1,267,000,000USD | 1,264,000,000USD | 1,394,000,000USD | 1,552,000,000USD | 1,825,000,000USD | 2,075,000,000USD | 2,819,000,000USD |
| Stock Based Compensation | 216,000,000USD | 150,000,000USD | 132,000,000USD | 126,000,000USD | 128,000,000USD | 105,000,000USD | 102,000,000USD | 87,000,000USD |
| Other Non Cash Items | -1,166,289USD | 179,000,000USD | 778,000,000USD | -1,464,000,000USD | 1,036,000,000USD | 581,000,000USD | 1,655,000,000USD | 2,865,000,000USD |
| Change To Account Receivables | -136,345,741USD | -216,000,000USD | -195,000,000USD | -57,000,000USD | -229,000,000USD | 170,000,000USD | 39,000,000USD | 216,000,000USD |
| Change To Inventory | -12,210,066USD | -267,000,000USD | -322,000,000USD | -198,000,000USD | -16,000,000USD | -77,000,000USD | -209,000,000USD | -5,000,000USD |
| Change In Working Capital | -222,833,711USD | 7,000,000USD | -582,000,000USD | -396,000,000USD | -128,000,000USD | -366,000,000USD | -318,000,000USD | 18,000,000USD |
| Total Cash From Operating Activities | 1,400,000,000USD | 1,597,000,000USD | 1,032,000,000USD | -728,000,000USD | 1,426,000,000USD | 1,111,000,000USD | 1,501,000,000USD | 1,501,000,000USD |
| Capital Expenditures | -397,000,000USD | -337,000,000USD | -272,000,000USD | -268,000,000USD | -283,000,000USD | -309,000,000USD | -278,000,000USD | -235,000,000USD |
| Free Cash Flow | 1,003,000,000USD | 1,260,000,000USD | 760,000,000USD | -996,000,000USD | 1,143,000,000USD | 802,000,000USD | 1,223,000,000USD | 1,266,000,000USD |
| Investments | -3,000,000USD | -454,000,000USD | -2,133,000,000USD | 5,000,000USD | -4,000,000USD | 4,000,000USD | -6,000,000USD | -196,000,000USD |
| Total Cashflows From Investing Activities | -595,000,000USD | -454,000,000USD | -2,145,000,000USD | -303,000,000USD | 409,000,000USD | -261,000,000USD | -419,000,000USD | -196,000,000USD |
| Net Borrowings | -637,000,000USD | -799,000,000USD | 1,581,000,000USD | -1,081,000,000USD | -1,388,000,000USD | -2,226,000,000USD | 1,526,000,000USD | -1,262,000,000USD |
| Total Cash From Financing Activities | -742,000,000USD | -868,000,000USD | 1,475,000,000USD | -474,000,000USD | -1,513,000,000USD | -2,294,000,000USD | 1,443,000,000USD | -1,353,000,000USD |
| Change In Cash | 124,000,000USD | 239,000,000USD | 371,000,000USD | -1,528,000,000USD | 303,000,000USD | -1,428,000,000USD | 2,521,000,000USD | -74,000,000USD |
| Begin Period Cash Flow | 1,201,000,000USD | 962,000,000USD | 591,000,000USD | 2,119,000,000USD | 1,816,000,000USD | 3,244,000,000USD | 723,000,000USD | 797,000,000USD |
| End Period Cash Flow | 1,325,000,000USD | 1,201,000,000USD | 962,000,000USD | 591,000,000USD | 2,119,000,000USD | 1,816,000,000USD | 3,244,000,000USD | 723,000,000USD |
| Other Cashflows From Investing Activities | -195,000,000USD | -119,000,000USD | -39,000,000USD | -45,000,000USD | 682,000,000USD | 37,000,000USD | 45,000,000USD | 34,000,000USD |
| Other Cashflows From Financing Activities | -93,848,976USD | -43,000,000USD | -106,000,000USD | -139,000,000USD | -173,000,000USD | -107,000,000USD | -71,000,000USD | -186,000,000USD |
| Unclassified Operating Cash Flow | 80,000,000USD | 66,000,000USD | 51,000,000USD | -176,000,000USD | -225,000,000USD | -475,000,000USD | -230,000,000USD | -144,000,000USD |
| Unclassified Financing Cash Flow | -11,151,024USD | — | 24,000,000USD | 808,000,000USD | 100,000,000USD | 69,000,000USD | 28,000,000USD | 105,000,000USD |
| Sale Purchase Of Stock | — | -26,000,000USD | -24,000,000USD | -31,000,000USD | -52,000,000USD | -30,000,000USD | -40,000,000USD | -10,000,000USD |
| Issuance Of Capital Stock | — | 0USD | 0USD | 675,000,000USD | 0USD | 0USD | — | — |
| Unclassified Investing Cash Flow | — | 456,000,000USD | 299,000,000USD | 5,000,000USD | 14,000,000USD | 7,000,000USD | -180,000,000USD | 201,000,000USD |
| Change To Liabilities | — | — | — | -75,000,000USD | 121,000,000USD | -471,000,000USD | -149,000,000USD | -121,000,000USD |
| Dividends Paid | — | — | — | -31,000,000USD | — | — | — | — |
| Cash And Cash Equivalents Changes | — | — | — | -1,505,000,000USD | 322,000,000USD | -1,444,000,000USD | 2,525,000,000USD | -74,000,000USD |
| Exchange Rate Changes | — | — | — | — | — | — | — | -26,000,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Product | Price Appreciation Credit | 2,000,000 | USD | 0000885590-26-000053 |
| Q1 2026Quarterly · 2026-03-31 | Product | Product | 2,500,000,000 | USD | 0000885590-26-000053 |
| Q1 2026Quarterly · 2026-03-31 | Product | Product And Service Other | 24,000,000 | USD | 0000885590-26-000053 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Bausch Lomb | 1,244,000,000 | USD | 0000885590-26-000053 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Diversified | 185,000,000 | USD | 0000885590-26-000053 |
| Q1 2026Quarterly · 2026-03-31 | Segment | International Rx | 285,000,000 | USD | 0000885590-26-000053 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Salix | 639,000,000 | USD | 0000885590-26-000053 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Solta Medical | 171,000,000 | USD | 0000885590-26-000053 |
| Q4 2025Quarterly · 2025-12-31 | Segment | Bausch Lomb | 1,405,000,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Diversified | 255,000,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | International Rx | 306,000,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Salix | 693,000,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Solta Medical | 137,000,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Geography | Canada | 417,000,000 | USD | 0000885590-26-000023 |
| FY 2025Yearly · 2025-12-31 | Geography | China | 493,000,000 | USD | 0000885590-26-000023 |
| FY 2025Yearly · 2025-12-31 | Geography | ES | 109,000,000 | USD | 0000885590-26-000023 |
| FY 2025Yearly · 2025-12-31 | Geography | France | 249,000,000 | USD | 0000885590-26-000023 |
| FY 2025Yearly · 2025-12-31 | Geography | Germany | 176,000,000 | USD | 0000885590-26-000023 |
| FY 2025Yearly · 2025-12-31 | Geography | Italy | 106,000,000 | USD | 0000885590-26-000023 |
| FY 2025Yearly · 2025-12-31 | Geography | Japan | 192,000,000 | USD | 0000885590-26-000023 |
| FY 2025Yearly · 2025-12-31 | Geography | MX | 278,000,000 | USD | 0000885590-26-000023 |
| FY 2025Yearly · 2025-12-31 | Geography | Other Countries | 1,153,000,000 | USD | 0000885590-26-000023 |
| FY 2025Yearly · 2025-12-31 | Geography | PL | 382,000,000 | USD | 0000885590-26-000023 |
| FY 2025Yearly · 2025-12-31 | Geography | RU | 198,000,000 | USD | 0000885590-26-000023 |
| FY 2025Yearly · 2025-12-31 | Geography | South Korea | 234,000,000 | USD | 0000885590-26-000023 |
| FY 2025Yearly · 2025-12-31 | Geography | United Kingdom | 141,000,000 | USD | 0000885590-26-000023 |
| FY 2025Yearly · 2025-12-31 | Geography | United Statesand Puerto Rico | 6,138,000,000 | USD | 0000885590-26-000023 |
| FY 2025Yearly · 2025-12-31 | Product | Brandedand Other Generic Products | 962,000,000 | USD | 0000885590-26-000023 |
| FY 2025Yearly · 2025-12-31 | Product | Device Products | 2,439,000,000 | USD | 0000885590-26-000023 |
| FY 2025Yearly · 2025-12-31 | Product | Other Revenues | 110,000,000 | USD | 0000885590-26-000023 |
| FY 2025Yearly · 2025-12-31 | Product | Overthe Counter Products | 2,008,000,000 | USD | 0000885590-26-000023 |
| FY 2025Yearly · 2025-12-31 | Product | Pharmaceutical Products | 4,747,000,000 | USD | 0000885590-26-000023 |
| FY 2025Yearly · 2025-12-31 | Product | Price Appreciation Credit | 18,000,000 | USD | 0000885590-26-000023 |
| FY 2025Yearly · 2025-12-31 | Segment | Bausch Lomb | 5,101,000,000 | USD | 0000885590-26-000023 |
| FY 2025Yearly · 2025-12-31 | Segment | Diversified | 937,000,000 | USD | 0000885590-26-000023 |
| FY 2025Yearly · 2025-12-31 | Segment | International Rx | 1,132,000,000 | USD | 0000885590-26-000023 |
| FY 2025Yearly · 2025-12-31 | Segment | Salix | 2,578,000,000 | USD | 0000885590-26-000023 |
| FY 2025Yearly · 2025-12-31 | Segment | Solta Medical | 518,000,000 | USD | 0000885590-26-000023 |
| Q3 2025Quarterly · 2025-09-30 | Product | Product | 2,657,000,000 | USD | 0000885590-25-000051 |
| Q3 2025Quarterly · 2025-09-30 | Product | Product And Service Other | 24,000,000 | USD | 0000885590-25-000051 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Bausch Lomb | 1,281,000,000 | USD | 0000885590-25-000051 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Diversified | 258,000,000 | USD | 0000885590-25-000051 |
| Q3 2025Quarterly · 2025-09-30 | Segment | International Rx | 286,000,000 | USD | 0000885590-25-000051 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Salix | 716,000,000 | USD | 0000885590-25-000051 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Solta Medical | 140,000,000 | USD | 0000885590-25-000051 |
| Q2 2025Quarterly · 2025-06-30 | Product | Product | 2,504,000,000 | USD | 0000885590-25-000032 |
| Q2 2025Quarterly · 2025-06-30 | Product | Product And Service Other | 26,000,000 | USD | 0000885590-25-000032 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Bausch Lomb | 1,278,000,000 | USD | 0000885590-25-000032 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Diversified | 219,000,000 | USD | 0000885590-25-000032 |
| Q2 2025Quarterly · 2025-06-30 | Segment | International Rx | 278,000,000 | USD | 0000885590-25-000032 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Salix | 627,000,000 | USD | 0000885590-25-000032 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Solta Medical | 128,000,000 | USD | 0000885590-25-000032 |
| Q1 2025Quarterly · 2025-03-31 | Product | Price Appreciation Credit | 2,000,000 | USD | 0000885590-26-000053 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product | 2,227,000,000 | USD | 0000885590-26-000053 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product And Service Other | 32,000,000 | USD | 0000885590-26-000053 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Bausch Lomb | 1,137,000,000 | USD | 0000885590-26-000053 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Diversified | 205,000,000 | USD | 0000885590-26-000053 |
| Q1 2025Quarterly · 2025-03-31 | Segment | International Rx | 262,000,000 | USD | 0000885590-26-000053 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Salix | 542,000,000 | USD | 0000885590-26-000053 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Solta Medical | 113,000,000 | USD | 0000885590-26-000053 |
| Q4 2024Quarterly · 2024-12-31 | Segment | Bausch Lomb | 1,280,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Diversified | 228,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | International Rx | 279,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Salix | 634,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Solta Medical | 138,000,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Geography | Canada | 402,000,000 | USD | 0000885590-26-000023 |
| FY 2024Yearly · 2024-12-31 | Geography | China | 496,000,000 | USD | 0000885590-26-000023 |
| FY 2024Yearly · 2024-12-31 | Geography | ES | 99,000,000 | USD | 0000885590-26-000023 |
| FY 2024Yearly · 2024-12-31 | Geography | France | 230,000,000 | USD | 0000885590-26-000023 |
| FY 2024Yearly · 2024-12-31 | Geography | Germany | 159,000,000 | USD | 0000885590-26-000023 |
| FY 2024Yearly · 2024-12-31 | Geography | Italy | 94,000,000 | USD | 0000885590-26-000023 |
| FY 2024Yearly · 2024-12-31 | Geography | Japan | 188,000,000 | USD | 0000885590-26-000023 |
| FY 2024Yearly · 2024-12-31 | Geography | MX | 315,000,000 | USD | 0000885590-26-000023 |
| FY 2024Yearly · 2024-12-31 | Geography | Other Countries | 1,083,000,000 | USD | 0000885590-26-000023 |
| FY 2024Yearly · 2024-12-31 | Geography | PL | 350,000,000 | USD | 0000885590-26-000023 |
| FY 2024Yearly · 2024-12-31 | Geography | RU | 161,000,000 | USD | 0000885590-26-000023 |
| FY 2024Yearly · 2024-12-31 | Geography | South Korea | 146,000,000 | USD | 0000885590-26-000023 |
| FY 2024Yearly · 2024-12-31 | Geography | United Kingdom | 135,000,000 | USD | 0000885590-26-000023 |
| FY 2024Yearly · 2024-12-31 | Geography | United Statesand Puerto Rico | 5,767,000,000 | USD | 0000885590-26-000023 |
| FY 2024Yearly · 2024-12-31 | Product | Brandedand Other Generic Products | 979,000,000 | USD | 0000885590-26-000023 |
| FY 2024Yearly · 2024-12-31 | Product | Device Products | 2,240,000,000 | USD | 0000885590-26-000023 |
| FY 2024Yearly · 2024-12-31 | Product | Other Revenues | 107,000,000 | USD | 0000885590-26-000023 |
| FY 2024Yearly · 2024-12-31 | Product | Overthe Counter Products | 1,903,000,000 | USD | 0000885590-26-000023 |
| FY 2024Yearly · 2024-12-31 | Product | Pharmaceutical Products | 4,396,000,000 | USD | 0000885590-26-000023 |
| FY 2024Yearly · 2024-12-31 | Product | Price Appreciation Credit | 18,000,000 | USD | 0000885590-26-000023 |
| FY 2024Yearly · 2024-12-31 | Segment | Bausch Lomb | 4,791,000,000 | USD | 0000885590-26-000023 |
| FY 2024Yearly · 2024-12-31 | Segment | Diversified | 950,000,000 | USD | 0000885590-26-000023 |
| FY 2024Yearly · 2024-12-31 | Segment | International Rx | 1,111,000,000 | USD | 0000885590-26-000023 |
| FY 2024Yearly · 2024-12-31 | Segment | Salix | 2,333,000,000 | USD | 0000885590-26-000023 |
| FY 2024Yearly · 2024-12-31 | Segment | Solta Medical | 440,000,000 | USD | 0000885590-26-000023 |
| Q4 2024Quarterly · 2024-12-31 | Geography | Canada | 109,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | China | 145,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | ES | 28,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | France | 52,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | Germany | 34,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | Italy | 23,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | Japan | 52,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | MX | 67,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | Other Countries | 292,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | PL | 94,000,000 | USD | Legacy provider |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.